Bank Of New York Mellon Corp Oragenics Inc Transaction History

Bank Of New York Mellon Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 06, 2020	BUY	$0.43 - $0.75 $0 - $0	1 Added 0.01%	20,001 $11,000
Q2 2018 Aug 06, 2018	SELL	$1.16 - $2.0 $439 - $758	-379 Reduced 1.86%	20,000 $28,000
Q1 2018 May 15, 2018	BUY	$1.6 - $3.17 $32,606 - $64,601	20,379 New	20,379 $36,000

Ticker OGEN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 116,395,000
Market Cap $36.1M
Description
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immuni...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.